Literature DB >> 8261834

Gastric ulcers differ from duodenal ulcers. Evaluation of basal acid output.

M J Collen1, M J Sheridan.   

Abstract

Patients with pyloric channel and prepyloric gastric ulcers are often considered to have an ulcer diathesis similar to patients with duodenal ulcers, while patients with more proximal gastric ulcers (ie, fundus, body, antrum) are excluded. To evaluate possible differences in basal acid outputs with regard to gastric ulcer location, basal acid outputs were determined by nasogastric suction in 80 patients with endoscopically documented benign active gastric ulcers. The results were compared to 65 normal subjects and 155 patients with endoscopically documented duodenal ulcers. There were no significant differences in basal acid outputs among the 80 patients with gastric ulcers with regard to location (ie, fundus-body, antrum, prepyloric, channel), and no significant differences compared to the 65 normal subjects. However, basal acid output for the 155 patients with duodenal ulcers was significantly different from the 80 patients with gastric ulcers (P < 0.05) and the 65 normal subjects (P < 0.05). Basal acid outputs tended to be higher and there was more gastric acid hypersecretion when gastric ulcers were located near the pylorus. However, irrespective of gastric ulcer location, basal acid outputs were higher in patients with duodenal ulcers. Seventy-one of the 80 patients with gastric ulcers were treated for eight weeks with standard doses of antisecretory medications, and endoscopic healing or nonhealing was documented. In 60 patients their gastric ulcers completely healed, while 11 patients had nonhealed gastric ulcers. There were no significant differences between the two groups with regard to gender, mean age, or basal acid output.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8261834     DOI: 10.1007/bf01299909

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  GASTRIC ULCER.

Authors:  A FRANKEL; A E KARK
Journal:  Am J Gastroenterol       Date:  1965-07       Impact factor: 10.864

2.  Note on the epidemiology of peptic ulcer.

Authors:  E B WILSON
Journal:  Proc Natl Acad Sci U S A       Date:  1962-11-15       Impact factor: 11.205

Review 3.  Omeprazole.

Authors:  P N Maton
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

4.  Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis.

Authors:  W Dekker; G N Tytgat
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

5.  Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).

Authors:  M J Collen; V J Stanczak; C A Ciarleglio
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

6.  Gastritis and acid secretion in patients with gastric ulcers and duodenal ulcers.

Authors:  S Aukee
Journal:  Scand J Gastroenterol       Date:  1972       Impact factor: 2.423

7.  Maximal histalog test in control subjects and patients with peptic ulcer.

Authors:  K G Wormsley; M I Grossman
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

8.  Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.

Authors:  J P Raufman; S M Collins; S J Pandol; L Y Korman; M J Collen; M J Cornelius; M K Feld; D M McCarthy; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

9.  Gastric and duodenal ulcer are each many different diseases.

Authors:  J I Rotter
Journal:  Dig Dis Sci       Date:  1981-02       Impact factor: 3.199

Review 10.  The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates.

Authors:  C W Howden; D B Jones; K E Peace; D W Burget; R H Hunt
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

View more
  3 in total

1.  Definition for idiopathic gastric acid hypersecretion. A statistical and functional evaluation.

Authors:  M J Collen; M J Sheridan
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

2.  Idiopathic gastric acid hypersecretion. Comparison with Zollinger-Ellison syndrome.

Authors:  M J Collen; R T Jensen
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

3.  Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.

Authors:  M J Collen; J F Wirshup
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.